ConductScience.org, home

Paper3143363

Modulation of polyamine biosynthesis and transport by oncogene transfection.

Chang BK and 3 others. Biochem Biophys Res Commun, 1988. Cited by 43 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Modulation of polyamine biosynthesis and transport by oncogene transfection. Papers, record 3143363. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3143363

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modulation of polyamine biosynthesis and transport by oncogene transfection.
PubMed
Journal
Biochem Biophys Res Commun
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
1.07
iCite
Revised in PubMed
2019-06-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chang BKB K
2Libby PRP R
3Bergeron RJR J
4Porter CWC W

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell Transformation, NeoplasticMajor topic
OncogenesMajor topic
PolyaminesMajor topic
Animals
Biological Transport
Cell Division
Cell Line
Eflornithine
Genes, ras
Rats
Spermine
Transfection

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-13038NCI NIH HHSUnited StatesP01CA013038PubMed and NIHNIH RePORTER
CA-22153NCI NIH HHSUnited StatesR01CA022153PubMed and NIHNIH RePORTER

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
42,909,811Citrullinated histone H3 and elevated polyamine metabolism gene expression in peripheral blood polymorphonuclear leukocytes as biomarkers for poor immunotherapy response in cancer patients.Mol Biomed2026https://conductscience.org/library/papers/42909811PubMed
38,903,130A PET probe targeting polyamine transport system for precise tumor diagnosis and therapy.Asian J Pharm Sci2024https://conductscience.org/library/papers/38903130PubMed
38,169,949Microbial metabolites are involved in tumorigenesis and development by regulating immune responses.Front Immunol2023https://conductscience.org/library/papers/38169949PubMed
37,893,077Loss of Anti-Tumor Efficacy by Polyamine Blocking Therapy in GCN2 Null Mice.Biomedicines2023https://conductscience.org/library/papers/37893077PubMed
32,747,421Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade.Mol Cancer Ther2020https://conductscience.org/library/papers/32747421PubMed
29,401,744Elevated Polyamines in Saliva of Pancreatic Cancer.Cancers (Basel)2018https://conductscience.org/library/papers/29401744PubMed
29,304,009A Novel Polyamine-Targeted Therapy for BRAF Mutant Melanoma Tumors.Med Sci (Basel)2018https://conductscience.org/library/papers/29304009PubMed
29,137,411A novel polyamine blockade therapy activates an anti-tumor immune response.Oncotarget2017https://conductscience.org/library/papers/29137411PubMed
27,429,841ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers.Am J Cancer Res2016https://conductscience.org/library/papers/27429841PubMed
11,972,449Antizyme induction by polyamine analogues as a factor of cell growth inhibition.Biochem J2002https://conductscience.org/library/papers/11972449PubMed
8,870,644Substrate protection against inactivation of the mammalian polyamine-transport system by 1-ethyl-3-(3-dimethylaminopropyl)carbodi-imide.Biochem J1996https://conductscience.org/library/papers/8870644PubMed
8,251,070Recombinant human IL-6 expressed in E. coli undergoes selective N-terminal degradation: evidence that the protein consists of a stable core and a nonessential flexible N-terminal.J Protein Chem1993https://conductscience.org/library/papers/8251070PubMed
2,512,913Expression of a human gene for polyamine transport in Chinese-hamster ovary cells.Biochem J1989https://conductscience.org/library/papers/2512913PubMed
1,628,366Regulatory and antiproliferative effects of N-alkylated polyamine analogues in human and hamster pancreatic adenocarcinoma cell lines.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1628366PubMed
1,628,365Antitumor effects of N-alkylated polyamine analogues in human pancreatic adenocarcinoma models.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1628365PubMed
1,280,331Ornithine decarboxylase activity is critical for cell transformation.Nature1992https://conductscience.org/library/papers/1280331PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3143363

GET https://conductscience.org/api/papers/v1/3143363/authors